ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.
Robbins LLP issued a shareholder-solicitation notice naming ADMA Biologics, reminding investors of a class action lawsuit filed on behalf of purchasers between August 9, 2024, and March 25, 2026. The complaint alleges undisclosed related-party transactions, channel stuffing, and inadequate internal controls, stemming from a Culper Research report alleging -3% real growth versus +20% reported.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.